Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × veliparib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Rituximab 25 acalabrutinib 14 Cyclophosphamide 13 ibrutinib 12 venetoclax 11 zanubrutinib 9 Magnetic Resonance Spectroscopy 9 pirtobrutinib 8 obinutuzumab 8 glofitamab 8 fludarabine 8 Lenalidomide 8 CT-P10 8 Bendamustine Hydrochloride 8 Specimen Handling 7 Cytarabine 6 Biopsy 6 fludarabine phosphate 5 brexucabtagene autoleucel 4 Vincristine 4 Doxorubicin 4 Prednisone 3 Cyclosporine 3 palbociclib 2 Whole-Body Irradiation 2 Therapeutics 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡